-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BJ-001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BJ-001 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BJ-001 in Non-Small Cell Lung Cancer Drug Details: BJ-001 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Diphtheria + Haemophilus Influenzae [serotype B] + Hepatitis B + Pertussis (whole Cell) + Poliomyelitis + Tetanus) (hexavalent) Vaccine in Diphtheria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Diphtheria + Haemophilus Influenzae [serotype B] + Hepatitis B + Pertussis (whole Cell) + Poliomyelitis + Tetanus) (hexavalent) Vaccine in Diphtheria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using...
-
Company Insights
Innovation and Patenting activity of BJ~s Restaurants Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BJ~s Restaurants Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BJ-005 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BJ-005 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BJ-005 in Solid Tumor Drug Details: BJ-005 is under development for...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVB-001 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVB-001 in Metastatic Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVB-001 in Metastatic Ovarian Cancer Drug Details: AVB-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tusamitamab Ravtansine in Epithelial Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tusamitamab Ravtansine in Epithelial Ovarian Cancer Drug Details: Tusamitamab ravtansine is under development for the treatment...
-
Product Insights
UITM Gambang Solar PV Park
UITM Gambang Solar PV Park is a solar PV project located in Pahang, Malaysia. The project is owned and developed by BJ Power Co Ltd; Perwira Al Shura Consulting Engineers Sdn Bhd. The project came online in 2019. Empower your strategies with our UITM Gambang Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ciclopirox in Porphyria (Erythropoietic Protoporphyri)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ciclopirox in Porphyria (Erythropoietic Protoporphyri) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ciclopirox in Porphyria (Erythropoietic Protoporphyri)Drug Details:Ciclopirox is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pulmonary Arterial Hypertension in Pulmonary Arterial Hypertension
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Arterial Hypertension in Pulmonary Arterial Hypertension Drug Details: The drug candidate is under...